*please note, all times listed are in Eastern Time (ET)
- This event has passed.
Clinical trial of pemigatinib, atezolizumab, and bevacizumab for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusion or rearrangement
February 13 @ 4:00 pm - 5:00 pm
